CHRISTINA WEILAND: Open Payments
NPI 1912309766 · FLORENCE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$834 in 38 payments from 13 companies in 2025. Trend: 2023 $1,446 · 2024 $896 · 2025 $834
Food & beverage: $834
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $358 |
| Gilead Sciences, Inc. | 5 | $99 |
| PFIZER INC. | 4 | $64 |
| Astellas Pharma US Inc | 3 | $62 |
| Exact Sciences Corporation | 2 | $56 |
| Lundbeck LLC | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Inspire Medical Systems, Inc. | 1 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $16 |
Products named: UBRELVY, VRAYLAR, Veozah, Cologuard Collection Kit, NURTEC ODT, REXULTI, TRELEGY ELLIPTA, QULIPTA.
Industry payments across KY — which companies pay providers there.
